
FDA, in policy shift, publishes some drug rejection letters
The Food and Drug Administration on Thursday published more than 200 drug rejection letters in a notable policy shift it said will pull back the curtain on feedback the agency gives to biotechnology and pharmaceutical companies. The FDA has not …